Jessika Valero-González, PhD, is the Chief Research Officer at BioClonal, where she leads groundbreaking projects in monoclonal antibody discovery and advanced therapeutic delivery systems. With a PhD in molecular biology and over a decade of experience in biotechnology, Jessika has pioneered the development of BioClonal’s proprietary antibody platform, which focuses on overcoming immunization barriers for complex targets. Her scientific work has contributed significantly to the fields of oncology and genetic disorders.
